ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Cytokinetics cans lead drug after phase 3 ALS wipeout
fiercebiotech
November 22, 2017Researchers set out to learn whether tirasemtiv, a fast skeletal muscle troponin activator, could drive greater improvements on a measure of lung capacity than placebo over 24 weeks. Tirasemtiv failed to clear that bar.
Pharma Sources Insight July 2025
